Breast Cancer [neop]
KeV [qnco]
Concern [idcn]
oncologists [prog]
Tamoxifen [orch, phsu]
treatment [ftcn]
PREVENT [phsu]
Breast Cancer [neop]
High Risk [qlco]
Women [popg]
Central [spco]
TOPIC [ftcn]
ASCO [pros]
Edition [inpr]
Rationale [idcn]
Europe [geoa]
Rest [dora]
Experimental [qlco]
Adjuvant Trials [resa]
Hormone Therapy [topp]
Decreased [qnco]
Risks [qlco]
Opposite [spco]
Breast [bpoc]
Cardiovascular disease [dsyn]
Osteoporosis [dsyn]
effects [qlco]
Make [ftcn]
Tamoxifen [orch, phsu]
Attractive [qlco]
Breast Cancer Prevention Trial [resa]
postmenopausal [tmco]
Women [popg]
premenopausal [tmco]
Women [popg]
preventive [ftcn]
Tamoxifen [orch, phsu]
View [spco]
Special [qlco]
Increased [qnco]
Second Cancer [neop]
Reported [inpr]
Dosages [qnco]
Suggest [idcn]
preventive therapy [inpr]
difficulties [fndg]
Familial form [fndg]
Value [qnco]
Anthracyclines [antb, orch]
adjuvant therapy [topp]
Several [qnco]
dose-response relationship [biof]
Reported [inpr]
Anthracyclines [antb, orch]
adjuvant therapy [topp]
metastatic disease [neop]
Dose-Limiting [idcn]
Toxic effect [inpo]
Including [ftcn]
Thrombocytopenia [fndg]
Mucitis [patf]
Dosages [qnco]
Increased [qnco]
Concomitant Therapy [topp]
rG-CSF [aapp, imft, phsu]
Patients [podg]
Metastases [neop]
Taxol [orch, phsu]
promise [idcn]
Drug [phsu]
ONGOING [idcn]
Phase I Trial [resa]
Optimal [qlco]
Dosage [qnco]
Administration [ocac]
modalities [idcn]
Taxol [orch, phsu]
Doxorubicin [antb, orch]
Combination [qlco]
